Home
About
Overview
Sharing Data
ORCID
Help
History (6)
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer.
Molecular evolution of A-kinase anchoring protein (AKAP)-7: implications in comparative PKA compartmentalization.
Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy.
Rosiglitazone reduces glucose-stimulated insulin secretion rate and increases insulin clearance in nondiabetic, insulin-resistant individuals.
Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation.
Genetic and Nongenetic Risk Factors for Breast Cancer Risk Estimation. JAMA Netw Open. 2025 Apr 01; 8(4):e255804.
View in:
PubMed
subject areas
Adult
Breast Neoplasms
Cameroon
Case-Control Studies
Female
Genetic Predisposition to Disease
Humans
Middle Aged
Nigeria
Risk Assessment
Risk Factors
Uganda
authors with profiles
Yonglan Zheng
Dezheng Huo